Clinical trial
TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee…
NCT00130468 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00130468 |
|---|---|
| Title | TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis |
| Official title | A Double Blind, Randomized Trial of Intra-Articular Injections of 20 mg of Hyalgan® for the Treatment of Knee Pain Due to Osteoarthritis (Three Injection-Regimen for Efficacy And Duration-20 mg/2mL Dose: Tread-20) |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Hyalgan (sodium hyaluronate) |
| Enrollment | 150 |
| Start date | Nov 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Aug 15, 2005 |
| Last update posted | Apr 3, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: